UK-based insurer Aviva said on May 25 that it will start a share buy-back of its ordinary shares for up to a maximum consideration of £300 million.
Aviva has entered into a non-discretionary agreement with Morgan Stanley to enable the purchase of Aviva ordinary shares by Morgan Stanley, acting as principal, during the period running from 25 May 2017 and ending no later than 15 December 2017.
Shares acquired by Morgan Stanley under the agreement will be simultaneously on-sold to Aviva. To the extent permitted by law, such ordinary shares purchased will be cancelled.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk